Philophos
PrivateLast Round
Series A
Jan 24, 2022
Total Funding Raised
$1.51M
Company Overview
Philophos operates in Healthcare & Life Sciences and is based in Daejeon. Its latest recorded funding round was a Series A round in January 2022.
Philophos is a medical device company that develops and manufactures portable, low-cost optical coherence tomography (OCT) systems for medical diagnostics and tele-ophthalmology applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Sensors, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Philophos Comparables
Compare Philophos with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lumedica Vision | 86% | |
| Tishyas Medical Device Development Solutions | 84% | |
| Siloton | 82% |
For institutional investors. Book with your work email.
Philophos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 24, 2022 | ||||
| Pre Seed | Oct 17, 2019 | ||||
| Accelerator | May 21, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Philophos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bluepoint Partners | Pre Seed |
| Dadam Investment | Series A |
| ROI Investment Partners | Series A |
| ETRI Holdings | Pre Seed |
| Korea Venture Investment Corporation | Series A |
| Industrial Bank of Korea | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 24, 2022
Raised $1.51M from Dadam Investment and kban-or.
- Oct 17, 2019
Raised Pre Seed round with Bluepoint Partners and ETRI Holdings.
For institutional investors. Book with your work email.
Philophos Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Philophos's valuation, stock price, and market status.
Is Philophos a public or private company?
Philophos is a private company.
What is the current stock price of Philophos?
Philophos is a private company, so its shares have no public market price. Caplight tracks Philophos's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Philophos worth (valuation)?
Valuation information for Philophos is not publicly available.
Can I buy Philophos stock?
Philophos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Philophos's last funding round?
Philophos's most recent funding round was Series A on January 24, 2022.
Who are the main investors in Philophos?
Key investors in Philophos include Bluepoint Partners, Dadam Investment, ROI Investment Partners, ETRI Holdings, Korea Venture Investment Corporation.
Will Philophos IPO soon?
No public IPO plans have been announced for Philophos.
How can I track Philophos secondary market activity?
Caplight tracks bids, offers, and trades in Philophos's shares on secondary markets.